| 1 | Blood, human or animal, antisera, other blood fractions and immunological products: immunological products, put up in measured doses or in forms or packings for retail saleHS6 300215 - six-digit product code | $764.8M | 0% | 0.3 | Watch |
|---|
| 2 | Medicaments: consisting of mixed or unmixed products n.e.s. in heading no. 3004, for therapeutic or prophylactic uses, packaged for retail saleHS6 300490 - six-digit product code | $919.3M | 42% | 0.5 | Watch |
|---|
| 3 | Heterocyclic compounds: containing an unfused pyridine ring (whether or not hydrogenated) in the structure, other than pyridine and its salts, other than piperidine and its saltsHS6 293339 - six-digit product code | $193.9M | 40.3% | 1.7 | High attention |
|---|
| 4 | Blood, human or animal, antisera, other blood fractions and immunological products: antisera and other blood fractionsHS6 300212 - six-digit product code | $130.1M | 0% | 0.3 | Watch |
|---|
| 5 | Cyclic amides (including cyclic carbamates) and their derivatives: other than the derivatives and salts of ureines, 2-acetamidobenzoic acid (N-acetylanthancillic acid), and ethinamate SHS6 292429 - six-digit product code | $103.8M | 0% | 1.3 | High attention |
|---|
| 6 | Wrist-watches: whether or not incorporating a stop-watch facility, with automatic windingHS6 910221 - six-digit product code | $23.4M | 0% | 0.6 | High attention |
|---|
| 7 | Coffee: roasted, not decaffeinatedHS6 090121 - six-digit product code | $39.3M | 0% | 0.9 | High attention |
|---|
| 8 | Organic derivatives of hydrazine or of hydroxylamineHS6 292800 - six-digit product code | $29.4M | 74.2% | 1 | Critical attention |
|---|
| 9 | Heterocyclic compounds: with nitrogen hetero-atom(s) only, containing an unfused pyrazole ring (whether or not hydrogenated) in the structure, other than henazone (antipyrin) and its derivativesHS6 293319 - six-digit product code | $46.0M | 4.1% | 2 | High attention |
|---|
| 10 | Ink: for printing, other than black, whether or not concentrated or solidHS6 321519 - six-digit product code | $28.0M | 68.6% | 0.7 | High attention |
|---|